A 60-year-old woman comes to the emergency room in a coma. The patient’s temperature is 32.2degC (90degF). She is bradycardic. Her thyroid gland is enlarged. There is diffuse hyporeflexia. BP is 100/60. Which of the following is the best next step in management?
**Core Concept**
The patient's presentation is suggestive of hypothyroidism, specifically myxedema coma, a life-threatening complication of untreated or severe hypothyroidism. Myxedema coma is characterized by severe hypothermia, bradycardia, and reduced reflexes.
**Why the Correct Answer is Right**
The management of myxedema coma involves the administration of thyroid hormone replacement therapy. Levothyroxine (T4) is the preferred initial treatment, as it is easier to administer and has a longer half-life compared to triiodothyronine (T3). T4 is converted to T3 in the body, which is the active form of thyroid hormone. The initial dose of T4 is typically 200-500 mcg, which is then adjusted based on the patient's response. Additionally, the patient may require supportive care, including warming, hydration, and cardiovascular support.
**Why Each Wrong Option is Incorrect**
**Option A:** Administration of glucocorticoids is not the best initial step in managing myxedema coma. While glucocorticoids may be used to treat adrenal insufficiency, which can coexist with hypothyroidism, they do not address the primary issue of hypothyroidism.
**Option B:** The use of vasopressors to manage the patient's hypotension is not the best next step. While vasopressors may be used to support blood pressure, the underlying cause of the hypotension is hypothyroidism, and addressing this with thyroid hormone replacement therapy is more important.
**Option C:** Administration of activated charcoal is not relevant in this scenario. Myxedema coma is a medical emergency that requires urgent administration of thyroid hormone replacement therapy, not gastrointestinal decontamination.
**Option D:** The use of antipyretics to manage the patient's hypothermia is not the best next step. While antipyretics may help to raise the patient's body temperature, the underlying cause of the hypothermia is hypothyroidism, and addressing this with thyroid hormone replacement therapy is more important.
**Clinical Pearl / High-Yield Fact**
The "4 Ts" of myxedema coma are: **T**emperature < 35°C, **T**achycardia (not bradycardia), **T**achypnea, and **T**remors (not hyporeflexia). This mnemonic can help identify patients with myxedema coma and guide their management.
**Correct Answer:** C. Levothyroxine (T4) is the best next step in managing myxedema coma, as it provides thyroid hormone replacement therapy and addresses the underlying cause of the patient's symptoms.